Medical Therapy for Endometriosis: Endocrine Pharmacology
review
OA: closed
CC0
⤵ 13 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the endocrine pharmacology of medical therapies used to treat endometriosis, focusing on hormonal mechanisms and treatment strategies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (13)
- Diagnosis and management of chronic pelvic pain 2002
- Endometriosis: An Overview of the Disease and Its Treatment 2000
- Effects of chocolate cyst fluid on endometrioma cell growth in culture 1998
- Endometriose 1998
- Immunosuppressive effect of danazol on lymphocyte-mediated cytotoxicity toward human endometrial stromal cells 1994
- Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis 1992
- Endometriose 1992
- Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity 1992
- Endometriosis—the role of medroxyprogesterone acetate 1992
- Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component* 1989
- Case 6-1988 1988
- Pelvic Endometriosis 1987
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK